Delivery Order SPE2DB24D2101-SPE2DB25FKJNT

Award Date 4/11/25
Potential Completion Date 4/14/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,172.84, is for the supply of 4,567,278,594 units of Duloxetine HCL DR 60 MG capsules. The award is a Firm Fixed Price delivery order placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4,566,824,824 units of Duloxetine HCL DR 40 mg capsules, with a ceiling value of $1,046.01. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA, which provides a comprehensive range of pharmaceutical products and...
This federal contract award is for the delivery of 4,562,525,346 units of Duloxetine HCL DR 60 MG capsules to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,900.93 and was awarded to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is October 19, 2023. The contract is not designated with a set-aside requirement, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,352,877 units of Duloxetine HCL DR 60 mg Capsules in 90-count packages, with a ceiling value of $1,153.76. The contract is a Firm Fixed Price Delivery Order with a period of performance running through February 25, 2025. This award is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,674.67 firm fixed-price delivery order is for the supply of 4,564,690 units of Duloxetine HCL DR 40 mg capsules. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
The U.S. Defense Logistics Agency (DLA) awarded a $5,123.29 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 1,000 units of Duloxetine HCl DR 60 mg capsules. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $1,025.40 firm fixed-price delivery order is for the supply of 4,564,377,705 units of Duloxetine HCL DR 40 mg capsules. The contract has an ultimate completion date of April 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,025.21 firm fixed-price contract is for the delivery of 4,564,428,298 units of Duloxetine Hydrochloride Delayed-Release 60 milligram capsules. This order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,961.25 firm fixed-price delivery order is for the supply of 4566789424 - Duloxetine HCL DR 40 MG capsules, with a completion date of December 24, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award is a delivery order issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,215.82 firm fixed-price contract is for the delivery of 4,566,516,150 units of Duloxetine HCL DR 40 MG capsules. The contract has an ultimate completion date of November 22, 2024 and was awarded on November 21, 2024. No set-aside designation was used for this award....
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB25FKJNT
    Delivery Order

This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a $1,991.97 Delivery Order, is for the supply of 4,567,887,153 units of Duloxetine HCL DR 60 MG capsules. The contract has an ultimate completion date of April 14, 2025 and is a Firm Fixed Price contract type. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 7/11/25, 10:06 AM